<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>Research in 2017 | ARSACS</title>
	<atom:link href="https://arsacs.com/fr/category/2017/feed/" rel="self" type="application/rss+xml" />
	<link>https://arsacs.com/fr</link>
	<description>Research That Heals</description>
	<lastBuildDate>Mon, 16 Mar 2026 22:09:52 +0000</lastBuildDate>
	<language>fr-CA</language>
	<sy:updateperiod>
	hourly	</sy:updateperiod>
	<sy:updatefrequency>
	1	</sy:updatefrequency>
	

<image>
	<url>https://arsacs.com/wp-content/uploads/2021/02/cropped-FAVICON-32x32.png</url>
	<title>Research in 2017 | ARSACS</title>
	<link>https://arsacs.com/fr</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>ARSACS project gets grant from Italian Ministry of Health</title>
		<link>https://arsacs.com/fr/arsacs-project-gets-grant-from-italian-ministry-of-health-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Mon, 04 Jun 2018 20:15:38 +0000</pubDate>
				<category><![CDATA[Research in 2017]]></category>
		<guid ispermalink="false">https://clone.arsacs.com/arsacs-project-gets-grant-from-italian-ministry-of-health-2/</guid>

					<description><![CDATA[The Italian Ministry of Health will fund the project “Insight into new therapeutic preclinical strategies in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay type” presented by: Summary of the Project: "Autosomal recessive spastic-ataxia of Charlevoix-Saguenay (ARSACS) is a multisystem hereditary ataxia associated with mutations in SACS, encoding sacsin, a protein whose function is only in part [...]]]></description>
										<content:encoded><![CDATA[The Italian Ministry of Health will fund the project “Insight into new therapeutic preclinical strategies in Autosomal Recessive Spastic
Ataxia of Charlevoix-Saguenay type” presented by:

<div id="attachment_99" style="width: 160px" class="wp-caption alignleft"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-99" class="wp-image-99 size-thumbnail" src="https://arsacs.com/wp-content/uploads/2021/02/Filippo_Santorelli-150x150-2.jpg" alt="" width="150" height="150"><p id="caption-attachment-99" class="wp-caption-text">Dr. Filippo M. Santorelli, Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa.</p></div>

<div id="attachment_234" style="width: 160px" class="wp-caption alignleft"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-234" class="wp-image-234 size-thumbnail" src="https://arsacs.com/wp-content/uploads/2021/02/DrFrancescaMaltecca-150x150-2.jpg" alt="Dre Francesca Maltecca" width="150" height="150"><p id="caption-attachment-234" class="wp-caption-text">Dr. Francesca Maltecca, Neurogenomics Unit, Ospedale San Raffaele, Milan, Italy</p></div>

<div id="attachment_3151" style="width: 160px" class="wp-caption alignleft"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-3151" class="size-thumbnail wp-image-3151" src="https://arsacs.com/wp-content/uploads/2021/02/Dr.-Ciofani-150x150-2.jpg" alt="" width="150" height="150"><p id="caption-attachment-3151" class="wp-caption-text">Dr. Gianni Ciofani, Smart Bio-Interfaces, Istituto Italiano di Tecnologia (IIT), Pontedera (PI)</p></div>

<div style="clear: both;"><strong>Summary of the Project:</strong></div>
"Autosomal recessive spastic-ataxia of Charlevoix-Saguenay (ARSACS) is a multisystem hereditary ataxia associated with mutations in SACS, encoding sacsin, a protein whose function is only in part understood. Mutations in SACS impair chaperone-mediated protein-folding activity and mitochondrial(mt) dynamics in Sacs knock-out (KO) mice and human ARSACS cells. Our challenge is to find tools capable to reverse sacsin defects in mice and to identify biomarkers of efficacy in clinical trials. We will use a dual approach: we will analyze mt functionality in Purkinje cells needed to fine tuning new treatment opportunities in Sacs KO mice and will seek for prognostic/predictive biomarkers in patients in order to design new intervention strategies aimed at overcoming brain alterations. To cope with brain alterations in ARSACS and in similar neurological conditions with altered mt functionality, we will also test new nanovectors to easy drug delivery in mutant cells."]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Completing the first high-throughput drug screening using an ARSACS fibroblast assay – Dr. Bernard Brais and Dr. Michel Bouvier</title>
		<link>https://arsacs.com/fr/completing-the-first-high-throughput-drug-screening-using-an-arsacs-fibroblast-assay-dr-bernard-brais-and-dr-michel-bouvier-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Thu, 31 Aug 2017 17:46:19 +0000</pubDate>
				<category><![CDATA[Research in 2017]]></category>
		<guid ispermalink="false">https://clone.arsacs.com/completing-the-first-high-throughput-drug-screening-using-an-arsacs-fibroblast-assay-dr-bernard-brais-and-dr-michel-bouvier/</guid>

					<description><![CDATA[Project description to come &#160; Duration : One year Grant: $100,000 Contacts: Dr. Bernard Brais, co-director of the neuromuscular group of the Montreal Neurological Institute and Hospital 3801 University Street Montreal, Quebec, Canada H3A 2B4 Tel:(514)-398-3334; Email: bernard.brais@mcgill.ca &#160; &#160; &#160; &#160; &#160; &#160; Dr.Michel Bouuvier, Institute for Research in Immunology and Cancer  (IRIC) Université [...]]]></description>
										<content:encoded><![CDATA[Project description to come

&nbsp;

Duration : One year
Grant: $100,000
Contacts:

<div id="attachment_192" style="width: 160px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-192" class="size-thumbnail wp-image-192" src="https://arsacs.com/wordpress/wp-content/uploads/2016/03/Brais_2015-150x150.jpg" alt="Dr. Bernard Brais" width="150" height="150" /><p id="caption-attachment-192" class="wp-caption-text">Dr. Bernard Brais</p></div>

Dr. Bernard Brais, co-director of the neuromuscular group of the Montreal Neurological Institute and Hospital
3801 University Street Montreal, Quebec, Canada H3A 2B4
Tel:(514)-398-3334; Email: <a href="mailto:bernard.brais@mcgill.ca">bernard.brais@mcgill.ca</a>

&nbsp;

<img loading="lazy" decoding="async" class="size-thumbnail wp-image-2441 alignleft" src="https://arsacs.com/wp-content/uploads/2021/02/Michel_Bouvier-150x150-2.jpg" alt="" width="150" height="150" />

&nbsp;

&nbsp;

&nbsp;

&nbsp;

&nbsp;

Dr.Michel Bouuvier, Institute for Research in Immunology and Cancer  (IRIC)

Université de Montréal | Pavillon Marcelle-Coutu | local 1306-5
Tel: (514)-343-6111 poste 0914 ; Email:  <a href="http://www.iric.ca/" target="_blank" rel="noopener noreferrer">www.iric.ca</a>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Complete the characterization of Sacsin Interacome and establish how it is modified in disease and by therapeutic compounds – Dr. Bernard Brais and Dr. Eric Shoubridge</title>
		<link>https://arsacs.com/fr/complete-the-characterization-of-sacsin-interacome-and-establish-how-it-is-modified-in-disease-and-by-therapeutic-compounds-dr-bernard-brais-and-dr-eric-shoubridge-3/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Thu, 31 Aug 2017 17:46:19 +0000</pubDate>
				<category><![CDATA[Research in 2017]]></category>
		<guid ispermalink="false">https://clone.arsacs.com/complete-the-characterization-of-sacsin-interacome-and-establish-how-it-is-modified-in-disease-and-by-therapeutic-compounds-dr-bernard-brais-and-dr-eric-shoubridge/</guid>

					<description><![CDATA[&#160; Project description to come &#160; &#160; Duration: one year Grant: $100,000 Contacts: Dr. Bernard Brais, co-director of the neuromuscular group of the Montreal Neurological Institute and Hospital 3801 University Street Montreal, Quebec, Canada H3A 2B4 Tel:(514)-398-3334; Email: bernard.brais@mcgill.ca Dr. Eric Shoubridge, Montreal Neurological Institute and Hospital 3801 University Street Montreal, Quebec, Canada H3A 2B4 [...]]]></description>
										<content:encoded><![CDATA[&nbsp;

Project description to come

&nbsp;

&nbsp;

Duration: one year
Grant: $100,000
Contacts:

<div id="attachment_192-2" style="width: 160px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-192-2" class="size-thumbnail wp-image-192" src="https://arsacs.com/wordpress/wp-content/uploads/2016/03/Brais_2015-150x150.jpg" alt="Dr. Bernard Brais" width="150" height="150" /><p id="caption-attachment-192-2" class="wp-caption-text">Dr. Bernard Brais</p></div>

Dr. Bernard Brais, co-director of the neuromuscular group of the Montreal Neurological Institute and Hospital
3801 University Street Montreal, Quebec, Canada H3A 2B4
Tel:(514)-398-3334; Email: <a href="mailto:bernard.brais@mcgill.ca">bernard.brais@mcgill.ca</a>

<div id="attachment_205" style="width: 135px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-205" class="size-thumbnail wp-image-205" src="https://arsacs.com/wordpress/wp-content/uploads/2016/03/DrEricShoubridge-125x150.gif" alt="Dr Eric Shoubridge" width="125" height="150" /><p id="caption-attachment-205" class="wp-caption-text">Dr Eric Shoubridge</p></div>

Dr. Eric Shoubridge, Montreal Neurological Institute and Hospital
3801 University Street Montreal, Quebec, Canada H3A 2B4
Tel: (514)-398-1997; Email: <a href="mailto:eric.shoubridge@mcgill.ca">eric.shoubridge@mcgill.ca</a>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Integrated Structural Studies Using Electron Microscopy and Cristallopraphy – Dr Kalle Gehring</title>
		<link>https://arsacs.com/fr/integrated-structural-studies-using-electron-microscopy-and-cristallopraphy-dr-kalle-gehring-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Thu, 31 Aug 2017 15:59:55 +0000</pubDate>
				<category><![CDATA[Research in 2017]]></category>
		<guid ispermalink="false">https://clone.arsacs.com/integrated-structural-studies-using-electron-microscopy-and-cristallopraphy-dr-kalle-gehring/</guid>

					<description><![CDATA[Project description to come. Duration: one year Grant: $98,350 Contact: Dr. Kalle Gehring, Professor Department of Biochemistry MCGill University Francesco Bellini Life Sciences Building, 3649 promenade Sir-William-Osler, Office: Room 469; Lab: Room 473, Montreal, Quebec H3G 0B1 Tel:(514)-398-7287; Lab: (514)-398-2873/1496; Fax:(514)-398-2983; Email: kalle.gehring@mcgill.ca]]></description>
										<content:encoded><![CDATA[Project description to come.

Duration: one year
Grant: $98,350
Contact:

<div id="attachment_216" style="width: 160px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-216" class="size-thumbnail wp-image-216" src="https://arsacs.com/wordpress/wp-content/uploads/2016/04/DrKalleGehring-150x150.jpg" alt="Dr Kalle Gehring" width="150" height="150" /><p id="caption-attachment-216" class="wp-caption-text">Dr Kalle Gehring</p></div>

Dr. Kalle Gehring, Professor Department of Biochemistry MCGill University
Francesco Bellini Life Sciences Building, 3649 promenade Sir-William-Osler, Office: Room 469; Lab: Room 473, Montreal, Quebec H3G 0B1
Tel:(514)-398-7287; Lab: (514)-398-2873/1496; Fax:(514)-398-2983; Email: <a href="mailto:kalle.gehring@mcgill.ca">kalle.gehring@mcgill.ca</a>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Role of Neurofilaments in the Pathogenic Cascade of ARSACS &#8211; Dr. Heather Durham</title>
		<link>https://arsacs.com/fr/role-of-neurofilaments-in-the-pathogenic-cascade-of-arsacs-dr-heather-durham-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Tue, 30 Aug 2016 18:06:51 +0000</pubDate>
				<category><![CDATA[Research in 2017]]></category>
		<guid ispermalink="false">https://clone.arsacs.com/role-of-neurofilaments-in-the-pathogenic-cascade-of-arsacs-dr-heather-durham/</guid>

					<description><![CDATA[&#160; Project description to come Duration: one year Grant: $100,000 Contact: Dr. Heather Durham, professor McGill University Tel:(514)-398-8509; Email: heather.durham@mcgill.ca]]></description>
										<content:encoded><![CDATA[&nbsp;

Project description to come

Duration: one year
Grant: $100,000
Contact:

<div id="attachment_189" style="width: 160px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-189" class="size-thumbnail wp-image-189" src="https://arsacs.com/wordpress/wp-content/uploads/2016/03/heather-durham-150x150.jpg" alt="Dr Heather Durham" width="150" height="150" /><p id="caption-attachment-189" class="wp-caption-text">Dr Heather Durham</p></div>

Dr. Heather Durham, professor McGill University
Tel:(514)-398-8509; Email: <a href="mailto:heather.durham@mcgill.ca">heather.durham@mcgill.ca</a>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Caractérisation des déficiences musculaires associées aux difficultés à la marche et aux transferts chez les patients atteints de l&#8217;ARSACS :de la cellule à la fonction- Dr Luc Hébert</title>
		<link>https://arsacs.com/fr/caracterisation-des-deficiences-musculaires-associees-aux-difficultes-a-la-marche-et-aux-transferts-chez-les-patients-atteints-de-larsacs-de-la-cellule-a-la-fonction-dr-luc-hebert-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Thu, 25 Aug 2016 22:47:32 +0000</pubDate>
				<category><![CDATA[Research in 2017]]></category>
		<guid ispermalink="false">https://clone.arsacs.com/caracterisation-des-deficiences-musculaires-associees-aux-difficultes-a-la-marche-et-aux-transferts-chez-les-patients-atteints-de-larsacs-de-la-cellule-a-la-fonction-dr-luc-hebert/</guid>

					<description><![CDATA[Caractériser les déficiences de force et de contrôle de mouvements volontaires et les limitations d'activité liées à la mobilité; 2) caractériser leurs interrelations; et 3) identifier les variables cliniques qui expliquent le mieux les limitations d'activités telle que la vitesse de marche.   Durée: un an Bourse : $73,300 Contact: Dr.Luc Hébert , Chercheur, CIRRIS, Bureau H-1702 [...]]]></description>
										<content:encoded><![CDATA[Caractériser les déficiences de force et de contrôle de mouvements volontaires et les limitations d'activité liées à la mobilité; 2) caractériser leurs interrelations; et 3) identifier les variables cliniques qui expliquent le mieux les limitations d'activités telle que la vitesse de marche.

<div id="attachment_1794" style="width: 258px" class="wp-caption alignright"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-1794" class="size-medium wp-image-1794" src="https://arsacs.com/wp-content/uploads/2021/02/Luc_J_Hebert-248x300-2.jpg" alt="Dr. Luc J. Hébert" width="248" height="300" /><p id="caption-attachment-1794" class="wp-caption-text">Dr. Luc J. Hébert</p></div>

<strong> </strong>

Durée: un an
Bourse : $73,300

Contact:

Dr.Luc Hébert , Chercheur, CIRRIS,

Bureau H-1702 . IRDPQ, 525 boulevard Hamel, Québec QC  G1M 2S8

Téléphone: 418-529-9141 poste 6579
<div> Courriel :  <a href="mailto:lucj.hebert@fmed.ulaval.ca">lucj.hebert@fmed.ulaval.ca</a>; <a href="mailto:ljhebert@videotron.ca">ljhebert@videotron.ca</a></div>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Disrupted Protein Homeostasis in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay- Dr. Paul Chapple</title>
		<link>https://arsacs.com/fr/disrupted-protein-homeostasis-in-autosomal-recessive-spastic-ataxia-of-charlevoix-saguenay-dr-paul-chapple-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Thu, 25 Aug 2016 22:47:32 +0000</pubDate>
				<category><![CDATA[Research in 2017]]></category>
		<guid ispermalink="false">https://clone.arsacs.com/disrupted-protein-homeostasis-in-autosomal-recessive-spastic-ataxia-of-charlevoix-saguenay-dr-paul-chapple/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Characterizing and Ameliorating Axonal Transport Defects in ARSACS Mice &#8211; Dr. Thomas Schwartz</title>
		<link>https://arsacs.com/fr/characterizing-and-ameliorating-axonal-transport-defects-in-arsacs-mice-dr-thomas-schwartz-2-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Wed, 24 Aug 2016 23:36:31 +0000</pubDate>
				<category><![CDATA[Research in 2017]]></category>
		<guid ispermalink="false">https://clone.arsacs.com/characterizing-and-ameliorating-axonal-transport-defects-in-arsacs-mice-dr-thomas-schwartz-2/</guid>

					<description><![CDATA[&#160; &#160; Project description to come &#160; Duration: one year Grant: $74,000USD Contact: Dr. Thomas L. Schwarz, Professor, F.M. Kirby Neurobiology Center Children's Hospital, Boston and Dept.of Neurobiology Harvard Medical School CLSB 12-130, 3 Blackfan Street, Boston, MA 02115 Tel:(617)-919-2219 (office) or (617)-919-2264 (lab)]]></description>
										<content:encoded><![CDATA[&nbsp;

&nbsp;

Project description to come

&nbsp;

Duration: one year

Grant: $74,000USD

Contact:

<div id="attachment_222" style="width: 160px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-222" class="size-thumbnail wp-image-222" src="https://arsacs.com/wordpress/wp-content/uploads/2016/04/Schwarz-150x150.jpg" alt="Dr. Thomas L. Schwarz" width="150" height="150" /><p id="caption-attachment-222" class="wp-caption-text">Dr. Thomas L. Schwarz</p></div>

Dr. Thomas L. Schwarz, Professor, F.M. Kirby Neurobiology Center Children's Hospital, Boston and Dept.of Neurobiology
Harvard Medical School CLSB 12-130, 3 Blackfan Street, Boston, MA 02115
Tel:(617)-919-2219 (office) or (617)-919-2264 (lab)]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Elucidating  mechanisms underlying motor coordination rescue in a mouse model of ARSACS &#8211; Dr. Alanna Watt and Dr. Anne McKinney.</title>
		<link>https://arsacs.com/fr/elucidating-mechanisms-underlying-motor-coordination-rescue-in-a-mouse-model-of-arsacs-dr-alanna-watt-and-dr-anne-mckinney-6/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Tue, 23 Aug 2016 23:19:06 +0000</pubDate>
				<category><![CDATA[Research in 2017]]></category>
		<guid ispermalink="false">https://clone.arsacs.com/elucidating-mechanisms-underlying-motor-coordination-rescue-in-a-mouse-model-of-arsacs-dr-alanna-watt-and-dr-anne-mckinney/</guid>

					<description><![CDATA[The McKinney and Watt labs, which are located in close proximity in the Bellini Life Sciences Complex and who already share a mouse colony of ARSACS mice (Sacs-/-) will determine the physiological mode of action of TPS-100 a pharma and aminopyridines on Purkinje cell function, including synaptic input and output. They will work closely together, [...]]]></description>
										<content:encoded><![CDATA[The McKinney and Watt labs, which are located in close proximity in the Bellini Life Sciences Complex and who already share a mouse colony of ARSACS mice (Sacs-/-) will determine the physiological mode of action of TPS-100 a pharma and aminopyridines on Purkinje cell function, including synaptic input and output. They will work closely together, to elucidate the mechanism of action of TPS-100, which has been shown to rescue motor function in ARSACS mice (personal communication,B. Brais), or similar other therapeutic agents. This work will advance the goal of a therapeutic intervention for ARSACS.

Duration: second year of the project
Grant: $165,000 per year
Contacts:

<div id="attachment_132" style="width: 160px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-132" class="size-thumbnail wp-image-132" src="https://arsacs.com/wordpress/wp-content/uploads/2016/03/watt-1-150x150.jpg" alt="Dre Alanna Watt" width="150" height="150" /><p id="caption-attachment-132" class="wp-caption-text">Dre Alanna Watt</p></div>

Dr. Alanna Watt, Department of Biology McGill University Bellini Life Sciences Bldg.
3469 Sir William Osler, Montreal, Quebec Canada H3G 0B1 Office: Rm. 265 | Lab: Rm. 257
Tel: (514)-398-2806; Fax: (514)-398-5069; Email: <a href="mailto:alanna.watt@mcgill.ca">alanna.watt@mcgill.ca</a>

<div id="attachment_186" style="width: 160px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-186" class="size-thumbnail wp-image-186" src="https://arsacs.com/wordpress/wp-content/uploads/2016/03/Anne-McKinney-150x150.jpg" alt="Anne McKinney" width="150" height="150" /><p id="caption-attachment-186" class="wp-caption-text">Anne McKinney</p></div>

Dr. Anne McKinney, Department of Pharmacology and Therapeutics,
McGill University Bellini Life Sciences Bldg
3469 Sir William Osler, Montreal, Quebec Canada H3G 0B1
Tel: (514)-398-5685; Fax: (514)-398-2045; Email: <a href="mailto:anne.mckinney@mcgill.ca">anne.mckinney@mcgill.ca</a>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Mapping drug-Sacsin interactions and mitochondrial assemblies in ARSACS patient fibroblasts &#8211; Dr.Mohan Babu</title>
		<link>https://arsacs.com/fr/mapping-drug-sacsin-interactions-and-mitochondrial-assemblies-in-arsacs-patient-fibroblasts-dr-mohan-babu-2/</link>
		
		<dc:creator><![CDATA[ARSACS]]></dc:creator>
		<pubDate>Sat, 02 Apr 2016 22:12:24 +0000</pubDate>
				<category><![CDATA[Research in 2017]]></category>
		<guid ispermalink="false">https://clone.arsacs.com/mapping-drug-sacsin-interactions-and-mitochondrial-assemblies-in-arsacs-patient-fibroblasts-dr-mohan-babu/</guid>

					<description><![CDATA[Aim 1- Mapping GI network of ARSACS-associated SACS target using CRISPR 1.1. Quantitative readout for scoring GIs 1.2. GI validation and benchmarking Aim 2 - Characterizing ARSACS-linked SACS pathways for function discovery Duration: one year Grant: $69,500 Contact: Dr.Mohan Babu, Asst. Professor CIHR New Investigator,Department of Biochemistry University of Regina Saskatchewan SK S4S 0A2 Tel:(306)-585-4192; [...]]]></description>
										<content:encoded><![CDATA[Aim 1- Mapping GI network of ARSACS-associated SACS target using CRISPR
1.1. Quantitative readout for scoring GIs
1.2. GI validation and benchmarking

Aim 2 - Characterizing ARSACS-linked SACS pathways for function discovery

Duration: one year
Grant: $69,500
Contact:

<div id="attachment_231" style="width: 142px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-231" class="size-full wp-image-231" src="https://arsacs.com/wordpress/wp-content/uploads/2016/04/DrMohanBabu.jpg" alt="Dr. Mohan Babu" width="132" height="148" /><p id="caption-attachment-231" class="wp-caption-text">Dr. Mohan Babu</p></div>

Dr.Mohan Babu, Asst. Professor CIHR New Investigator,Department of Biochemistry University of Regina
Saskatchewan SK S4S 0A2
Tel:(306)-585-4192; Email: <a href="mailto:mohan.babu@uregina.ca">mohan.babu@uregina.ca</a>]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>